Results 41 to 50 of about 245 (84)
Summary: COVID-19 is associated with complications of thrombosis because these patients need anticoagulant prophylaxes. An important task is the evaluation of hemostasis status and the efficiency of anticoagulant prophylaxes.
Смирнова, Ольга Анатольевна +4 more
core +1 more source
Studies data on new anticoagulants, direct oral thrombin inhibitor (dabigatran) and direct inhibitors of coagulation factor Xa (rivaroxaban, apixaban), in the treatment of nonvalvular atrial fibrillation are presented.
Z. M. Safiullina, S. V. Shalaev
doaj +1 more source
Динамика СОЭ при использовании различных стабилизаторов крови [PDF]
козы, кровь, гомеостаз организма, скорость оседания эритроцитов, антикоагулянты, лимоннокислый натрий ...
Щерба, Д. В.
core
Secondary prevention of venous thromboembolic complications. Focus on dabigatrane
Venous thromboembolic complications (VTEC) are a frequent pathology accompanied by high lethality. After VTEC the risk of their recurrence not equivalent for all patients remains.
V.Y. Bogachev +3 more
doaj
Cardioembolic complications such as ischemic stroke and non-central nervous system venous thrombosis are among the most serious consequences of atrial fibrillation (AF) [1, 2].
IS Yavelov
doaj +1 more source
Pulmonary embolism: inpatient and outpatient treatment
Pulmonary embolism (PE) is a rather common emergency situation. Occlusion of pulmonary arteries of different calibre may result in critical condition, shock, sudden death, while in a number of patients who survived thromboembolism it may lead to long ...
GE Gendlin +3 more
doaj +1 more source
Stroke patient seeing a neurologist
Stroke is one of the leading causes of death and disability of the population. Recently, there has been an increase in the incidence of stroke among people of working age and a "rejuvenation" of stroke.
A. S. Kadykov, N. V. Shakhparonova
doaj +1 more source
Профилактика инсульта у пациентов с неклапанной фибрилляцией предсердий: основные факторы риска и антитромботическая терапия [PDF]
фибрилляция предсердий, инсульт, факторы риска, оральные антикоагулянты: Фибрилляция предсердий ассоциирована с повышенным риском развития инсульта и других тромботических осложнений.
Сурмач, Е. И. +1 more
core
Pulmonary embolism. Diagnosis and treatment
The lecture is based on 2014 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism (APE) 2014. It tells about the prevalence, risk factors and etiology of APE.
N. B. Perepech
doaj +1 more source
The article is devoted to the current topic in neonatology – the development of thrombosis. The incidence of neonatal thrombosis and its risk factors are shown.
Елена Викторовна Мальцева +3 more
doaj

